西班牙原发性醛固酮增多症诊断、管理和随访共识执行摘要
原发性醛固酮增多症是继发性高血压最常见病因,较原发性高血压心血管代谢风险更高,但诊断率仍偏低。该西班牙共识由多个学会的多学科专家采用名义组共识法制定,旨在总结原发性醛固酮增多症诊断、管理和随访的推荐意见。
要点
- 原发性醛固酮增多症是继发性高血压最常见病因,与较高心血管代谢风险相关。
- 该病诊断率仍明显偏低,早期诊断和适当治疗对降低心血管代谢死亡风险至关重要。
- 随访同样重要,但既往临床实践指南对此提及很少。
核心结论
- 该执行摘要总结了西班牙原发性醛固酮增多症共识中关于诊断、管理和随访的推荐意见。
研究设计与样本
- 西班牙共识,由西班牙内分泌与营养学会(SEEN)、西班牙心脏病学会(SEC)、西班牙肾脏病学会(SEN)、西班牙内科学会(SEMI)、西班牙放射学会(SERAM)、西班牙血管与介入放射学会(SERVEI)、西班牙检验医学会(SEQC(ML))、西班牙解剖病理学会(EAP)和西班牙外科医师协会(AEC)的专家采用名义组共识法从多学科角度制定。
局限性
- 随访方面共识很少,且既往不同临床实践指南很少提及。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Primary hyperaldosteronism (PH) is the most common cause of secondary hypertension (HTN) and is associated with a higher cardiometabolic risk than essential HTN. Nevertheless, PH remains clearly underdiagnosed. An early diagnosis and adequate treatment of this disease are essential to reduce the cardiometabolic morbimortality associated with aldosterone excess. PH follow-up is equally essential; however, there is little consensus on how it should be performed, being a topic rarely mentioned by the different clinical practice guidelines. The aim of this executive summary is to summarize the recommendations made in the Spanish consensus of PH for the diagnosis, management, and follow-up of these patients. The Spanish consensus was reached from a multidisciplinary perspective through a nominal group consensus approach by experts from the Spanish Society of Endocrinology and Nutrition (SEEN), the Spanish Society of Cardiology (SEC), the Spanish Society of Nephrology (SEN), the Spanish Society of Internal Medicine (SEMI), the Spanish Society of Radiology (SERAM), the Spanish Society of Vascular and Interventional Radiology (SERVEI), the Spanish Society of Laboratory Medicine (SEQC(ML)), the Spanish Society of Anatomic-Pathology (EAP), and the Spanish Association of Surgeons (AEC).
引用
- Araujo-Castro M, Parra Ramírez P, Hanzu FA, et al. Executive summary of the Spanish consensus for the diagnosis, management, and follow-up of primary hyperaldosteronism. Endocrinol Diabetes Nutr (Engl Ed). 2024. PMID: 39374998. doi:10.1016/j.endien.2024.09.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。